Page last updated: 2024-10-30

mesalamine and Central Serous Chorioretinopathy

mesalamine has been researched along with Central Serous Chorioretinopathy in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Central Serous Chorioretinopathy: A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.

Research Excerpts

ExcerptRelevanceReference
"We report a case of a patient with ulcerative colitis and central serous retinopathy, which is a chronic ophthalmological condition that is frequently aggravated by corticosteroid treatment and may sometimes result in severe visual impairment."1.39A patient with ulcerative colitis and central serous chorioretinopathy--a therapeutic dilemma. ( Ben-Horin, S; Geyshis, B; Katz, G; Kopylov, U, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geyshis, B1
Katz, G1
Ben-Horin, S1
Kopylov, U1

Other Studies

1 other study available for mesalamine and Central Serous Chorioretinopathy

ArticleYear
A patient with ulcerative colitis and central serous chorioretinopathy--a therapeutic dilemma.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:2

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Central Serous Chorioretinopathy;

2013